LENSAR (LNSR) is being acquired by Alcon for $14 per share, with an additional CVR offering up to $2.75 based on future ...

Cedar Grove Capital Management, an investment management company, released its first quarter 2025 investor letter. A copy of ...

In its first quarter 2025 investor letter, Cedar Grove Capital Management emphasized stocks such as LENSAR, Inc. (NASDAQ:LNSR). LENSAR, Inc. (NASDAQ:LNSR) is a commercial-stage medical device company.

One rising WWE star is rapidly being replacing Brock Lesnar as the company’s most explosive ever star in the minds of fans. Lesnar was a phenom in WWE, not least in his formative years when, ...

60 Degrees Pharmaceuticals, Inc. develops medicines for the treatment and prevention of infectious diseases. Its product Arakoda helps in the prevention of malaria. The company was founded by ...

Eye care company Alcon Inc., which has a major presence in North Texas, plans to buy Lensar Inc. in a deal valued up to $430 million. Orlando-based Lensar (Nasdaq: LNSR) is a laser cataract ...